Communications
The reductive guanidinylation sequence is sufficiently
clean to effect the direct sulfonation of 14 and 15 at O12 to
give sulfates 16 and 17 in a combined yield of 66% from 13
after a single purification by HPLC. In the 1H NMR spectrum
of 16, the uracil proton at C5 is clearly evident at d =
5.72 ppm, and the resonances are well defined and closely
match those of 1, except for the methylene protons at C7. In
an attempt to reconcile these differences, this spectrum was
compared with the spectrum that had led to the elucidation of
the structure of 5. However, it is clear that the natural
material is a mixture of compounds, and it was not possible to
conclude whether 16 was a minor component of that mixture.
Most significantly, our synthetic 7-deoxycylindrospermop-
sin (16) proved to be a potent inhibitor of protein synthesis
in vitro, as measured in the rabbit reticulocyte lysate sys-
tem.[9b] Protein synthesis was completely inhibited at 12 mm
and partially inhibited at 500 nm. This effect on protein
synthesis was also evaluated in whole cells (Table 1).[2] As
seen, 16 completely inhibits protein synthesis at 10 mm, thus
displaying a potency that is within an order of magnitude of
natural 1. Synthetic 16 also inhibits the synthesis of gluta-
thione (GSH), in a similar fashion to 1.[3,9a]
Scheme 2. a) 3-Buten-2-ol, DIC, DMAP, CH2Cl2 (96%); b) 2.2 equiv
NaHMDS, THF, 08C!RT (99%); c) EtOCOCl, Et3N, THF, NaBH4,
H2O; d) AcCl, MeOH (60%, 2 steps); e) BrCH2CO2Ph, iPr2NEt, MeCN
(63–80%); f) mCPBA, Na2HPO4, CH2Cl2, ꢀ788C (84%); g) PhMe,
2008C, sealed tube, (78%); h) DIBAL-H, CH2Cl2, ꢀ788C (87%);
i) pMBNH2, H2/Pd/C, EtOAc then (p-O2NPhO)2CO, MeCN (81%);
j) TEMPO, PhI(OAc)2, 1 mol% MsOH, CDCl3 (75%); k) MeNO2,
nBuLi, THF, RT (84%); l) Ac2O, DMAP, CH2Cl2 then NaBH4, EtOH
(67%); m) TFA (neat), reflux (80%); n) Et3OBF4, Cs2CO3, CH2Cl2
(78%). DIC=diisopropylcarbodiimide, DMAP=4-dimethylaminopyri-
dine, HMDS=hexamethyldisilazide, Ac=acetyl, mCPBA=3-chloroper-
oxybenzoic acid, DIBAL-H=diisobutylaluminum hydride, pMB=para-
methoxybenzyl, TEMPO=tetramethylpiperidine-1-oxyl, MsOH=meth-
anesulfonic acid, TFA=trifluoroacetic acid. Boc=tert-butoxycarbonyl.
the hydroxymethyl group, thus affording good yields of the
sensitive ureido aldehyde 9.[11]
Intrigued by the possibility of conducting a reductive
guanidinylation sequence and simultaneously unmasking the
uracil unit, we first synthesized the dibenzyloxypyrimidine
aldehyde 12 (Scheme 3): A slightly modified procedure
permitted the substitution of 2,4,6-tribromopyrimidine (11)
with benzyl ether groups,[12] and formylation of the lithiated
pyrimidine with dimethylformamide (DMF) afforded 12 in
good yield. Treatment of 10 with 12 in the presence of acetic
anhydride and excess cesium fluoride couples these two units
directly and allows dehydration to occur in a single operation,
thus affording 13 in 67% yield. This nitroalkene was produced
as a single geometric isomer, which is presumed to be the
E isomer from studies of the NOE interactions of the
pyrimidine proton. Attempts to reduce the nitroalkene
directly to the corresponding saturated amine led predom-
inantly to hydrolysis of the presumed enamine intermediate.
To obviate this reactivity, sodium borohydride was
employed to reduce 13 to the nitroalkane. Hydrogenolysis
of this mixture reduced the nitroalkene, thus effecting
reductive guanidinylation, and cleanly cleaved the benzyl
ether groups to afford the uracil/guanidine compounds in an
approximate 1:1 mixture of isomers. Brief exposure of this
mixture to HCl facilitated the removal of the acetate group at
C12 to give 14 and 15. The configuration of 15 was ultimately
determined by X-ray crystallographic analysis.[13] It should be
noted that the guanidine moieties were obtained as trifluor-
oacetate salts after purification by HPLC. This method of
purification has been used in all of the previous syntheses of
2.[6b,14] The small amount of synthetic material produced did
not allow this counterion to be detected by 13C NMR
spectroscopy, but it is presumed to accompany the non-
zwitterionic guanidines purified by HPLC with trifluoroacetic
acid (TFA) in the eluent.
Scheme 3. a) BnOH, nBuLi, THF/DMF (80%); b) nBuLi, Et2O, DMF,
then 10% HCl (73%); c) 12, CsF, Ac2O, MeCN (67%); d) NaBH4,
EtOH then Pd(OH)2, H2, 5% AcOH/MeOH; e) HCl (conc.), reflux for
0.5 h (14=33%, 15=30%; 2 steps); f) SO3·py, DMF, 3-ꢀ MS
(16=33% from 13, 17=33% from 13). Bn=benzyl, py=pyridine,
MS=molecular sieves.
3880
ꢀ 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Angew. Chem. Int. Ed. 2005, 44, 3879 –3881